Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuliano Giova Volpiani

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Jornal Vascular Brasileiro|February 27, 2025
Topical oxybutynin deodorant for axillary hyperhidrosis: a topic or a systemic effect? Rationale and design of the phase II today trialSamantha Neves, Giuliano Giova Volpiani, Alexia Paganotti, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|December 8, 2025
Technical pitfalls and initial clinical experience using femoral staggered multibranch thoracoabdominal aneurysm repair techniqueJong Hun Park, Giuliano Giova Volpiani, Alvaro Razuk, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|April 4, 2026
A randomized controlled trial of 3% polidocanol foam with saline pre-washing compared to standard foam sclerotherapy for the treatment of varicose veinsLidiane Aparecida Ferreira Rocha, José Ben-Hur Ferraz Parente, Viviane Santana da Silva, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 21, 2026
ResponseLidiane Aparecida Ferreira Rocha, José Ben-Hur Ferraz Parente, Viviane Santana da Silva, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 18, 2025
Pulsed Electromagnetic Field Therapy Compared to Conventional Mechanical Prophylaxis for Venous Thromboembolism Prophylaxis in The Intensive Care Unit - Rationale and Design for The SOPHIE TrialEduardo Fonseca Sad, Samantha Neves, Maria Fernanda Portugal, et al.
Clinics (Sao Paulo, Brazil)|September 6, 2012
Carotid stenosis: what is the high-risk population?Jong Hun Park, Alvaro Razuk, Paulo Fernandes Saad, et al.
Phlebology|June 23, 2026
Q-switched and ultra-short-pulse Nd:YAG 1064 nm laser treatment for stasis dermatitis secondary to chronic venous hypertension: Rationale and design of the SUPERSTAR trialValéria Cristina Resende Aguiar, Marcelo Halfen Grill, Rodrigo Kikuchi, et al.
Annals of Vascular Surgery|November 13, 2025
Venous Thromboembolism in Patients Receiving Rivaroxaban Plus Aspirin or Standard Treatment after Lower Limb Revascularization-Rationale and Design of the RESOLUTION TrialGabriela de Oliveira Buril, Maria Fernanda Portugal, Samantha Neves, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 19, 2022
Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION TrialEduardo Ramacciotti, Leandro Barile Agati, Giuliano Giova Volpiani, et al.
Phlebology|September 4, 2025
Transdermal radiofrequency (V ERASER®) plus polidocanol sclerotherapy <i>versus</i> polidocanol sclerotherapy alone for the treatment of reticular veins and telangiectasias. A randomized controlled trial (TYPER trial)Rebeca Higino Becker, Roberto Augusto Caffaro, Caroline Cândida Carvalho de Oliveira, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Jornal Vascular Brasileiro|February 27, 2025
Topical oxybutynin deodorant for axillary hyperhidrosis: a topic or a systemic effect? Rationale and design of the phase II today trialSamantha Neves, Giuliano Giova Volpiani, Alexia Paganotti, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|December 8, 2025
Technical pitfalls and initial clinical experience using femoral staggered multibranch thoracoabdominal aneurysm repair techniqueJong Hun Park, Giuliano Giova Volpiani, Alvaro Razuk, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|April 4, 2026
A randomized controlled trial of 3% polidocanol foam with saline pre-washing compared to standard foam sclerotherapy for the treatment of varicose veinsLidiane Aparecida Ferreira Rocha, José Ben-Hur Ferraz Parente, Viviane Santana da Silva, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 21, 2026
ResponseLidiane Aparecida Ferreira Rocha, José Ben-Hur Ferraz Parente, Viviane Santana da Silva, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 18, 2025
Pulsed Electromagnetic Field Therapy Compared to Conventional Mechanical Prophylaxis for Venous Thromboembolism Prophylaxis in The Intensive Care Unit - Rationale and Design for The SOPHIE TrialEduardo Fonseca Sad, Samantha Neves, Maria Fernanda Portugal, et al.
Clinics (Sao Paulo, Brazil)|September 6, 2012
Carotid stenosis: what is the high-risk population?Jong Hun Park, Alvaro Razuk, Paulo Fernandes Saad, et al.
Phlebology|June 23, 2026
Q-switched and ultra-short-pulse Nd:YAG 1064 nm laser treatment for stasis dermatitis secondary to chronic venous hypertension: Rationale and design of the SUPERSTAR trialValéria Cristina Resende Aguiar, Marcelo Halfen Grill, Rodrigo Kikuchi, et al.
Annals of Vascular Surgery|November 13, 2025
Venous Thromboembolism in Patients Receiving Rivaroxaban Plus Aspirin or Standard Treatment after Lower Limb Revascularization-Rationale and Design of the RESOLUTION TrialGabriela de Oliveira Buril, Maria Fernanda Portugal, Samantha Neves, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 19, 2022
Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION TrialEduardo Ramacciotti, Leandro Barile Agati, Giuliano Giova Volpiani, et al.
Phlebology|September 4, 2025
Transdermal radiofrequency (V ERASER®) plus polidocanol sclerotherapy <i>versus</i> polidocanol sclerotherapy alone for the treatment of reticular veins and telangiectasias. A randomized controlled trial (TYPER trial)Rebeca Higino Becker, Roberto Augusto Caffaro, Caroline Cândida Carvalho de Oliveira, et al.
Pageof 2